{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:39:47Z","timestamp":1788489587500,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BBSRC strategic programme","award":["BBS\/E\/I\/00007034"],"award-info":[{"award-number":["BBS\/E\/I\/00007034"]}]},{"name":"BBSRC strategic programme","award":["BBS\/E\/I\/00007031"],"award-info":[{"award-number":["BBS\/E\/I\/00007031"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.coviro.2018.02.006","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T13:31:22Z","timestamp":1521379882000},"page":"33-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Recent advances in veterinary applications of structural vaccinology"],"prefix":"10.1016","volume":"29","author":[{"given":"Bryan","family":"Charleston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon P","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2018.02.006_bib0270","first-page":"9","article-title":"What are the most powerful immunogen design vaccine strategies? A structural biologist's perspective","author":"Kwong","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virusres.2010.07.016","article-title":"Porcine reproductive and respiratory syndrome in China","volume":"154","author":"Zhou","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1746-6148-6-30","article-title":"Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate","volume":"6","author":"Karniychuk","year":"2010","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vetmic.2012.11.024","article-title":"Increased pathogenicity of European porcine reproductive and respiratory syndrome virus is associated with enhanced adaptive responses and viral clearance","volume":"163","author":"Morgan","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0290","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.vetmic.2014.05.030","article-title":"Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge","volume":"172","author":"Park","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/1746-6148-8-182","article-title":"Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges","volume":"8","author":"Geldhof","year":"2012","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1297-9716-45-12","article-title":"Vaccination of sows against type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) before artificial insemination protects against type 2 PRRSV challenge but does not protect against type 1 PRRSV challenge in late gestation","volume":"45","author":"Han","year":"2014","journal-title":"Vet Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0305","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2004.05.008","article-title":"Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy","volume":"22","author":"Labarque","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tvjl.2007.01.021","article-title":"Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred","volume":"175","author":"Prieto","year":"2008","journal-title":"Vet J"},{"key":"10.1016\/j.coviro.2018.02.006_bib0315","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.vaccine.2014.03.077","article-title":"Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena","volume":"32","author":"Trus","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0320","first-page":"809","article-title":"Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV","volume":"161","author":"Scortti","year":"2007","journal-title":"Vet Rec"},{"key":"10.1016\/j.coviro.2018.02.006_bib0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.vetmic.2007.02.009","article-title":"Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge","volume":"123","author":"Zuckermann","year":"2007","journal-title":"Vet Microbiol"},{"issue":"Pt 5","key":"10.1016\/j.coviro.2018.02.006_bib0330","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1099\/0022-1317-79-5-989","article-title":"Immune response in pigs vaccinated with plasmid DNA encoding ORF5 of porcine reproductive and respiratory syndrome virus","volume":"79","author":"Pirzadeh","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0335","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1016\/j.vaccine.2004.03.028","article-title":"DNA vaccination of pigs with open reading frame 1\u20137 of PRRS virus","volume":"22","author":"Barfoed","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0340","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1016\/j.vaccine.2007.03.010","article-title":"Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5\/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18","volume":"25","author":"Shen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0345","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s11262-007-0161-5","article-title":"Co-expressing GP5 and M proteins under different promoters in recombinant modified vaccinia virus ankara (rMVA)-based vaccine vector enhanced the humoral and cellular immune responses of porcine reproductive and respiratory syndrome virus (PRRSV)","volume":"35","author":"Zheng","year":"2007","journal-title":"Virus Genes"},{"key":"10.1016\/j.coviro.2018.02.006_bib0350","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2009.01.098","article-title":"Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene","volume":"27","author":"Li","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0355","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1016\/j.vaccine.2010.09.002","article-title":"CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine","volume":"28","author":"Cao","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1128\/CVI.00304-06","article-title":"Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent","volume":"14","author":"Lopez","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0365","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/104063879400600326","article-title":"A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera","volume":"6","author":"Yoon","year":"1994","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.coviro.2018.02.006_bib0370","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0042-6822(03)00009-6","article-title":"Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination","volume":"309","author":"Meier","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2018.02.006_bib0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.virusres.2010.07.017","article-title":"Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology","volume":"154","author":"Darwich","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0380","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1016\/j.vaccine.2011.04.071","article-title":"Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies","volume":"29","author":"Vanhee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_bib0385","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1128\/JVI.71.8.6061-6067.1997","article-title":"Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus","volume":"71","author":"Meulenberg","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0390","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.vetimm.2004.09.011","article-title":"The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus","volume":"102","author":"Plagemann","year":"2004","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0395","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1099\/vir.0.18957-0","article-title":"The major envelope protein, GP5, of a European porcine reproductive and respiratory syndrome virus contains a neutralization epitope in its N-terminal ectodomain","volume":"84","author":"Wissink","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0400","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/JVI.76.9.4241-4250.2002","article-title":"Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain","volume":"76","author":"Ostrowski","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0405","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vetmic.2012.08.005","article-title":"Significance of genetic variation of PRRSV ORF5 in virus neutralization and molecular determinants corresponding to cross neutralization among PRRS viruses","volume":"162","author":"Kim","year":"2013","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0410","first-page":"6928","article-title":"Porcine Reproductive and Respiratory Syndrome Virus isolates differ in their susceptibility to neutralization","volume":"29","author":"Martinez-Lobo","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0415","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1128\/JVI.03287-14","article-title":"A single amino acid deletion in the matrix protein of porcine reproductive and respiratory syndrome virus confers resistance to a polyclonal Swine antibody with broadly neutralizing activity","volume":"89","author":"Trible","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.virusres.2015.03.016","article-title":"Broadly neutralizing antibodies against the rapidly evolving porcine reproductive and respiratory syndrome virus","volume":"203","author":"Robinson","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0425","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fmicb.2014.00329","article-title":"Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies","volume":"5","author":"Drummer","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0430","first-page":"323","article-title":"Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies","volume":"386","author":"Lee","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0435","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2015.03.006","article-title":"Influenza virus antigenicity and broadly neutralizing epitopes","volume":"11","author":"Air","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0440","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0445","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3285","article-title":"Tools to therapeutically harness the human antibody response","volume":"12","author":"Wilson","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2018.02.006_bib0455","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1128\/JVI.01079-15","article-title":"Human memory B cells producing potent cross-neutralizing antibodies against human parechovirus: implications for prevalence, treatment, and diagnosis","volume":"89","author":"Westerhuis","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0460","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1073\/pnas.1319058110","article-title":"A common solution to group 2 influenza virus neutralization","volume":"111","author":"Friesen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2018.02.006_bib0465","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/imr.12395","article-title":"Stable long-term cultures of self-renewing B cells and their applications","volume":"270","author":"Kwakkenbos","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0470","doi-asserted-by":"crossref","first-page":"e1003255","DOI":"10.1371\/journal.ppat.1003255","article-title":"Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen","volume":"9","author":"Porta","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0475","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsmb.3096","article-title":"Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design","volume":"22","author":"Kotecha","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0480","unstructured":"Kotecha A, Stuart DI, Fry EE, Esnouf RM: Stabilised FMDV capsids. US Patent 2014."},{"key":"10.1016\/j.coviro.2018.02.006_bib0485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1051\/vetres:2006053","article-title":"Bovine respiratory syncytial virus infection","volume":"38","author":"Valarcher","year":"2007","journal-title":"Vet Res"},{"key":"10.1016\/j.coviro.2018.02.006_bib0490","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus\u2014a comprehensive review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0495","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1439-0450.2000.00380.x","article-title":"High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian white blue calves previously vaccinated with an inactivated BRSV vaccine","volume":"47","author":"Schreiber","year":"2000","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.coviro.2018.02.006_bib0500","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1128\/JVI.77.22.12067-12073.2003","article-title":"Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis","volume":"77","author":"Antonis","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2018.02.006_bib0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/01652176.1989.9694231","article-title":"A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine","volume":"11","author":"Kimman","year":"1989","journal-title":"Vet Quart"},{"key":"10.1016\/j.coviro.2018.02.006_bib0510","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coviro.2018.02.006_bib0515","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0520","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2018.02.006_bib0525","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nsmb.3267","article-title":"Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV","volume":"23","author":"Joyce","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2018.02.006_sbref0530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-017-0005-9","article-title":"Protection of calves by a prefusion-stabilized bovine RSV F vaccine","volume":"2","author":"Zhang","year":"2017","journal-title":"NPJ Vaccines"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625718300166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625718300166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T08:38:06Z","timestamp":1603960686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625718300166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":53,"alternative-id":["S1879625718300166"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2018.02.006","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in veterinary applications of structural vaccinology","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2018.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}